Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: open-label randomized controlled trial (EFFaCo study) - Siripongboonsitti, T; Ungtrakul, T; Tawinprai, K (Int J Infect Di, 2023)
et al.